At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Restylane +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population
In Brief
A clinical study evaluating Restylane and Perlane for Healthy Volunteers. Completed, enrolled 100 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine after the first and second treatment when used for facial augmentation in Asian population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2015
Enrollment StartDec 2015
Primary CompletionDec 2016
Study CompletionSep 2018
TodayJul 2026
First PostedOct 1, 2015
Enrollment StartDec 1, 2015
Primary CompletionDec 29, 2016
Study CompletionSep 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.8 years ago
Interventions
Restylanedevice
Facial tissue augmentation
Perlanedevice
Facial tissue augmentation